EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer

Elise C Hoover iD, Olivia M Ruggiero, Rachel N Swingler, Emily S Day iD

ACS Omega · 26.03.2024 · 9 (12) · 14323-14335

DOI: 10.1021/acsomega.3c10275 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 16.03.2024. Verfasst von Elise C Hoover und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Delaware, Newark, Delaware 19713, United States. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute, University of Delaware.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Delaware, Newark, Delaware 19713, United States.
  • Department of Materials Science and Engineering, University of Delaware, Newark, Delaware 19716, United States.
  • Helen F. Graham Cancer Center and Research Institute, Newark, Delaware 19713, United States.

ORCID-Profile: Elise C Hoover, Emily S Day

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • University of Delaware

Zitieren

APA

Hoover, E. C., Ruggiero, O. M., Swingler, R. N., & Day, E. S. (2024). FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer. ACS Omega, 9(12), 14323-14335. https://doi.org/10.1021/acsomega.3c10275

Vancouver

Hoover EC, Ruggiero OM, Swingler RN, Day ES. FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer. ACS Omega. 2024;9(12):14323-14335. doi:10.1021/acsomega.3c10275

BibTeX
@article{Hoover2024,
  author = {Hoover, Elise C and Ruggiero, Olivia M and Swingler, Rachel N and Day, Emily S},
  title = {FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer},
  journal = {ACS Omega},
  year = {2024},
  volume = {9},
  number = {12},
  pages = {14323--14335},
  doi = {10.1021/acsomega.3c10275}
}
Kostenlos starten →